Discover Tenders by Miscellaneous Pharmaceuticals Sector

Find the most relevant tenders for Miscellaneous Pharmaceuticals. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Miscellaneous Pharmaceuticals tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Miscellaneous Pharmaceuticals tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Completion Not Excl Pharmaceutical Discount Club According To 130A Paragraph 8 Sgb V By Means Of An Open House Model To The Active Ingredient Epoetin Zeta Recombinant Human Erythropoetin

Deadline: 30 Apr 2027

Germany

Ref. No.: 13955053

EMD:Ref Document

Bid Value: Ref Document

448 Days Left

Completion Of Non Exclusive Discount Agreements According To 130 A 8 Sgb V With The Active Ingredient Infliximab For Intravenous Application

Deadline: 10 Feb 2027

Germany

Ref. No.: 13929708

EMD:Ref Document

Bid Value: Ref Document

369 Days Left

Completion Of Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Molizumab Vv 83

Deadline: 10 Feb 2027

Germany

Ref. No.: 13929656

EMD:Ref Document

Bid Value: Ref Document

369 Days Left

Completion Of Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Fluorouracil Tolak Vv 83

Deadline: 10 Feb 2027

Germany

Ref. No.: 13929414

EMD:Ref Document

Bid Value: Ref Document

369 Days Left

Completion Of Non Exclusive Discount Agreements According To Section 130A 8 Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 13927675

EMD:Ref Document

Bid Value: Ref Document

328 Days Left

Completion Of Non Exclusive Discount Agreements According To Section 130A 8 Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So Called Open House Process

Deadline: 31 Dec 2026

Germany

Ref. No.: 13921788

EMD:Ref Document

Bid Value: Ref Document

328 Days Left

Completion Of Non Exclusive Discount Agreements According To Section 130A 8 Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 13913990

EMD:Ref Document

Bid Value: Ref Document

328 Days Left

Completion Of Non Exclusive Discount Agreements According To 130 A 8 Sgb V With The Active Ingredient Infliximab For Subcutaneous Application

Deadline: 10 Feb 2027

Germany

Ref. No.: 13909924

EMD:Ref Document

Bid Value: Ref Document

369 Days Left

Completion Not Excl Pharmaceutical Discount Club According To Section 130A 8 Sgb V By Means Of An Open House Model To The Active Ingredient Interferon Beta 1A For Subcutaneous Injection Atc Code According To Who L03Ab07

Deadline: 30 Apr 2026

Germany

Ref. No.: 13870576

EMD:Ref Document

Bid Value: Ref Document

83 Days Left

Completion Of Non Exclusive Discount Agreements According To 130 A 8 Sgb V With The Active Ingredient Infliximab For Subcutaneous Application

Deadline: 10 Feb 2027

Germany

Ref. No.: 13845695

EMD:Ref Document

Bid Value: Ref Document

369 Days Left

Completion Of Non Exclusive Discount Agreements According To 130 A 8 Sgb V With The Active Ingredient Infliximab For Intravenous Application

Deadline: 10 Feb 2027

Germany

Ref. No.: 13844974

EMD:Ref Document

Bid Value: Ref Document

369 Days Left

Completion Of Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For Active Ingredients Drugs Vv 82

Deadline: 10 Feb 2027

Germany

Ref. No.: 13837037

EMD:Ref Document

Bid Value: Ref Document

369 Days Left

Completion Of Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Certolizumab Pegol Vv 82

Deadline: 10 Feb 2027

Germany

Ref. No.: 13788678

EMD:Ref Document

Bid Value: Ref Document

369 Days Left

Completion Of Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Clostridium Botulinum Toxin A Xeomin Vv 82

Deadline: 10 Feb 2027

Germany

Ref. No.: 13788654

EMD:Ref Document

Bid Value: Ref Document

369 Days Left

Completion Of Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Fentanyl Dihydrogencitrat Pecfent Vv 82

Deadline: 10 Feb 2027

Germany

Ref. No.: 13788628

EMD:Ref Document

Bid Value: Ref Document

369 Days Left

Showing 12166 to 12180 of 12892 results

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

FREE Trial plan for all new users!